Mortality rate during interferon alfa-ribavirin combination therapy of chronic hepatitis C

被引：1
|
作者：
Soza, A [1 ]
Hoofnagle, JH [1 ]
机构：
[1] NIDDKD, Liver Dis Sect, Digest Dis Branch, NIH, Bethesda, MD 20892 USA
来源：
HEPATOLOGY | 2003年 / 38卷 / 01期
关键词：
D O I：
10.1053/jhep.2003.50213
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：267 / 267
页数：1
相关论文
共 50 条
  • [21] Factors contributing to ribavirin dose reduction due to anemia during interferon alfa2b and ribavirin combination therapy for chronic hepatitis C
    Shintaro Takaki
    Akihito Tsubota
    Tetsuya Hosaka
    Norio Akuta
    Takashi Someya
    Masahiro Kobayashi
    Fumitaka Suzuki
    Yoshiyuki Suzuki
    Satoshi Saitoh
    Yasuji Arase
    Kenji Ikeda
    Hiromitsu Kumada
    Journal of Gastroenterology, 2004, 39 : 668 - 673
  • [22] Effectiveness of interferon alfa-2b/ribavirin combination therapy for chronic hepatitis C in a clinic setting
    Kumar, D
    Wallington-Beddoe, C
    George, J
    Lin, R
    Samarasinghe, D
    Liddle, C
    Farrell, GC
    MEDICAL JOURNAL OF AUSTRALIA, 2003, 178 (06) : 267 - 271
  • [23] Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin
    Foster, G. R.
    Zeuzem, S.
    Pianko, S.
    Sarin, S. K.
    Piratvisuth, T.
    Shah, S.
    Andreone, P.
    Sood, A.
    Chuang, W. -L.
    Lee, C. -M.
    George, J.
    Gould, M.
    Flisiak, R.
    Jacobson, I. M.
    Komolmit, P.
    Thongsawat, S.
    Tanwandee, T.
    Rasenack, J.
    Sola, R.
    Messina, I.
    Yin, Y.
    Cammarata, S.
    Feutren, G.
    Brown, K. K.
    JOURNAL OF VIRAL HEPATITIS, 2013, 20 (04) : e115 - e123
  • [24] Unmasking of myasthenia gravis during pegylated Alfa 2 a interferon and ribavirin therapy for chronic hepatitis C
    Saleem, Ayesha
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2016, 66 (05) : 618 - 620
  • [25] Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C
    Aizawa, Nobuhiro
    Enomoto, Hirayuki
    Takashima, Tomoyuki
    Sakai, Yoshiyuki
    Iwata, Kazunari
    Ikeda, Naoto
    Tanaka, Hironori
    Iwata, Yoshinori
    Saito, Masaki
    Imanishi, Hiroyasu
    Iijima, Hiroko
    Nishiguchi, Shuhei
    JOURNAL OF GASTROENTEROLOGY, 2014, 49 (08) : 1253 - 1263
  • [26] Interferon (IFN) induction therapy in combination with ribavirin in chronic hepatitis C
    Ferenci, P
    Brunner, H
    Vogel, W
    Gschwantler, M
    Datz, C
    Hackl, F
    Steindl-Munda, P
    Hofer, H
    JOURNAL OF HEPATOLOGY, 2000, 32 : 38 - 38
  • [27] Combination therapy with interferon and ribavirin in the treatment of chronic hepatitis C infection
    Battaglia, AM
    Hagmeyer, KO
    ANNALS OF PHARMACOTHERAPY, 2000, 34 (04) : 487 - 494
  • [28] Mutagenic effects of ribavirin and response to interferon/ribavirin combination therapy in chronic hepatitis C
    Asahina, Y
    Izumi, N
    Enomoto, N
    Uchihara, M
    Kurosaki, M
    Onuki, Y
    Nishimura, Y
    Ueda, K
    Tsuchiya, K
    Nakanishi, H
    Kitamura, T
    Miyake, S
    JOURNAL OF HEPATOLOGY, 2005, 43 (04) : 623 - 629
  • [29] Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C
    Nobuhiro Aizawa
    Hirayuki Enomoto
    Tomoyuki Takashima
    Yoshiyuki Sakai
    Kazunari Iwata
    Naoto Ikeda
    Hironori Tanaka
    Yoshinori Iwata
    Masaki Saito
    Hiroyasu Imanishi
    Hiroko Iijima
    Shuhei Nishiguchi
    Journal of Gastroenterology, 2014, 49 : 1253 - 1263
  • [30] Significance of serum ribavirin concentration in combination therapy of interferon and ribavirin for chronic hepatitis C
    Arase, Y
    Ikeda, K
    Tsubota, A
    Suzuki, F
    Suzuki, Y
    Saitoh, S
    Kobayashi, M
    Akuta, N
    Someya, T
    Hosaka, T
    Sezaki, H
    Kobayashi, M
    Kumada, H
    INTERVIROLOGY, 2005, 48 (2-3) : 138 - 144
12345